Biotech News

LeMaitre to Participate at Upcoming Investor Conferences in September

LeMaitre Vascular (LMAT)LeMaitre VascularConference / presentation

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences.

Wells Fargo 21 st Annual Healthcare Conference Tuesday, September 8, 2026, in Boston Dorian LeBlanc, CFO, will participate in a Fireside Chat at 8:45 AM ET

Morgan Stanley 24 th Annual Global Healthcare Conference Wednesday, September 16, 2026, in New York City Dorian LeBlanc, CFO, will participate in a Fireside Chat at 12:20 PM ET

19 th Annual Barrington Research Virtual Fall Investment Conference Tuesday, September 22, 2026 Dorian LeBlanc, CFO, time to be announced

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. For more information about the Company, please visit www.lemaitre.com.

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.

Contact: Sandra Millar LeMaitre Vascular, Inc. +1-781-425-1686 [email protected]

Related news

LeMaitre Vascular

LeMaitre Vascular is a medical device company serving vascular surgeons with implants, grafts, and related products. The business is rooted in procedure-linked vascular care.

Recent company news

Stock data

Close
79.47 USD
Market cap
2.09B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States